Activation of AKT is associated with metastasis of nasopharyngeal carcinoma.
about
Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 has a therapeutic potential and sensitizes cisplatin in nasopharyngeal carcinomaBMP2 promotes proliferation and invasion of nasopharyngeal carcinoma cells via mTORC1 pathwayEpstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.Expression profiling of 21 biomolecules in locally advanced nasopharyngeal carcinomas of Caucasian patients.Puquitinib mesylate (XC-302) induces autophagy via inhibiting the PI3K/AKT/mTOR signaling pathway in nasopharyngeal cancer cellsAs an independent unfavorable prognostic factor, IL-8 promotes metastasis of nasopharyngeal carcinoma through induction of epithelial-mesenchymal transition and activation of AKT signalingUpregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathwayIKBB tumor suppressive role in nasopharyngeal carcinoma via NF-κB-mediated signalling.Famitinib enhances nasopharyngeal cancer cell radiosensitivity by attenuating radiation-induced phosphorylation of platelet-derived growth factor receptor and c-kit and inhibiting microvessel formation.Decreased ARID1A expression facilitates cell proliferation and inhibits 5-fluorouracil-induced apoptosis in colorectal carcinoma.CIP2A is overexpressed in osteosarcoma and regulates cell proliferation and invasion.SIN1 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition.Improved antitumor effect of ionizing radiation in combination with rapamycin for treating nasopharyngeal carcinoma.Effect of AKT inhibition on epithelial-mesenchymal transition and ZEB1-potentiated radiotherapy in nasopharyngeal carcinoma.Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway.
P2860
Q27332333-EB73FF94-3D57-44D9-96BD-F335DEAAD68BQ33657520-F500CF26-F9AE-48B5-9A61-403EB0503EFBQ34483687-47027543-914E-4B51-9A7F-B6AFC54953A7Q34566972-A71593CF-8C71-4BEF-B0F8-C27817D18252Q35820811-71A41ECB-8A8F-4B70-9583-67A17D78B039Q36118892-C386027C-1C6B-4CCD-8C63-082315FA6169Q37046419-047469A3-7DCD-482E-9DD7-CF97088C7E91Q38847762-62ADDB11-3667-45BD-94C4-3C2C604B1ABDQ38864184-3BAC8013-5000-448B-BA2F-B60B80883C03Q38994522-1ADCB126-5FF2-4ED9-8AC3-BC375C0B4CE7Q39098575-5B130169-9C0F-4599-AB6B-F8434BC16FA4Q39169788-1FF18488-DB87-41F3-BEDF-5CD503D4436BQ40979448-065E924D-4C17-4F39-B154-E5064C822955Q42927132-C637AAD0-31E9-40DA-B80C-3B0C57B0935AQ47203446-00349E9E-8F93-49E6-9C3A-469FE5EBA236
P2860
Activation of AKT is associated with metastasis of nasopharyngeal carcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Activation of AKT is associated with metastasis of nasopharyngeal carcinoma.
@en
Activation of AKT is associated with metastasis of nasopharyngeal carcinoma.
@nl
type
label
Activation of AKT is associated with metastasis of nasopharyngeal carcinoma.
@en
Activation of AKT is associated with metastasis of nasopharyngeal carcinoma.
@nl
prefLabel
Activation of AKT is associated with metastasis of nasopharyngeal carcinoma.
@en
Activation of AKT is associated with metastasis of nasopharyngeal carcinoma.
@nl
P2093
P2860
P1433
P1476
Activation of AKT is associated with metastasis of nasopharyngeal carcinoma.
@en
P2093
Ai-Ming Sun
Long-Hua Chen
Qi-Sheng Li
Ya-Wei Yuan
P2860
P2888
P304
P356
10.1007/S13277-011-0272-4
P577
2011-11-25T00:00:00Z